EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features

Elena-Roxana Avădănei, Irina-Draga Căruntu, Ioana Păvăleanu, Andreea Ioana Pruteanu, Simona-Eliza Giușcă, Andreea Rusu, Gabriela Bordeianu, Ovidiu Bîcă, Ludmila Lozneanu

Current Issues in Molecular Biology · 18.11.2026 · 48 (11) · 1243

DOI: 10.3390/cimb48111243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.11.2026. Verfasst von Elena-Roxana Avădănei und 8 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian carcinoma (OC) is one of the most lethal gynecological malignancies. Galectin-8 (Gal-8) and the VEGF-C/VEGFR-3 lymphangiogenic axis have each been implicated in OC progression, but they have not been examined together in a histotype-resolved series. In this retrospective, cross-sectional, single-center study of 84 epithelial OC cases, Gal-8, VEGF-C and VEGFR-3 immunoexpression was related to histological type, Type I/Type II classification, pT-based stage and residual disease, with correction for multiple testing (q). Gal-8 was nuclear in all 34 high-grade serous carcinomas (HGSCs) and all 42 Type II tumors, whereas cytoplasmic and mixed patterns occurred almost only in low-grade and Type I tumors. A high Gal-8 score was associated with HGSC and Type II histology, poor differentiation, advanced stage and residual disease (odds ratios, all q ≤ 0.004). VEGF-C and VEGFR-3 were expressed in 67.86% and 73.81% of cases, more often in high-grade and advanced tumors, and in all stage III tumors. No statistically significant association was detected between Gal-8 and VEGF-C or VEGFR-3, but the cohort was too small for this comparison to be conclusive. Gal-8, VEGF-C and VEGFR-3 are each associated with aggressive features of OC. This study cannot show whether this reflects a shared aggressive phenotype or a functional interaction between the markers. Without outcome data or multivariable analysis, these findings are descriptive, not prognostic, and hypothesis-generating.

Zitieren

APA

Avădănei, E., Căruntu, I., Păvăleanu, I., Pruteanu, A. I., Giușcă, S., Rusu, A., Bordeianu, G., Bîcă, O., & Lozneanu, L. (2026). Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features. Current Issues in Molecular Biology, 48(11), 1243. https://doi.org/10.3390/cimb48111243

Vancouver

Avădănei E, Căruntu I, Păvăleanu I, Pruteanu AI, Giușcă S, Rusu A, et al. Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features. Current Issues in Molecular Biology. 2026;48(11):1243. doi:10.3390/cimb48111243

BibTeX
@article{Avdnei2026,
  author = {Avădănei, Elena-Roxana and Căruntu, Irina-Draga and Păvăleanu, Ioana and Pruteanu, Andreea Ioana and Giușcă, Simona-Eliza and Rusu, Andreea and Bordeianu, Gabriela and Bîcă, Ovidiu and Lozneanu, Ludmila},
  title = {Immunohistochemical Expression of Galectin-8, VEGF-C and VEGFR-3 in Epithelial Ovarian Carcinoma: Associations with Clinicopathological Features},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {11},
  pages = {1243},
  doi = {10.3390/cimb48111243}
}
Kostenlos starten →